Search results

1878 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
The Head and the Heart
Todd Cohen and Jonathan Schisler — a neuroscientist and a heart researcher — began working together in 2016 after meeting for coffee in Marsico Hall. By combining their expertise in protein studies, they strive to develop a potential treatment for Alzheimer’s disease.
Located in Vital Signs / 2020 / Jan. 23
Learning to Treat COVID-19 — Clinical Trials and Developing Therapeutics During a Pandemic
The American Public Health Association and the National Academy of Medicine are sponsoring a webinar series exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. UNC School of Medicine's Myron Cohen, MD, is part of an expert panel June 24.
Located in Vital Signs / 2020 / June 18
Hirsch Poised to Restore Sight to MPS I Patients Using Gene Therapy
Matthew Hirsch, PhD, assistant professor in the UNC Department of Ophthalmology and member of the UNC Gene Therapy Center, hopes to embark on a clinical trial this year to test the first ocular gene therapy that could restore the sight of patients suffering from a rare lysosomal storage disease.
Located in Vital Signs / 2020 / Feb. 13
NIH Funds UNC Study to Investigate Maternal-Fetal Transmission of Zika
UNC researchers led by Elizabeth Stringer, MD, Sylvia Becker-Dreps, MD, and Aravinda de Silva, PhD, along with collaborators in Nicaragua, have been given a five-year, $2.7 million R01 award from the U.S. National Institutes of Health (NIH) to better understand the epidemiology of Zika virus in pregnancy and the impact the virus has on infant neurodevelopment
Located in Vital Signs / 2018 / Sept. 27
ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership
This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center.
Located in News / 2020 / March
New grant will ‘re-engineer postnatal care’ to improve maternal and infant outcomes
The goal of the project is to identify and define priority unmet needs on postnatal units that contribute to poor maternal and infant outcomes and to create innovative recommendations to facilitate improved safety and wellness.
Located in Vital Signs / 2019 / Oct. 17
Temporary UNC Policy on Human Subjects-Related Research Visits at UNC-Chapel Hill during COVID-19 Outbreak
In light of recent State of North Carolina and University statements on COVID-19 and the rapidly evolving outbreak, UNC-Chapel Hill is issuing a temporary policy related to human subjects-related research visits.
Located in Vital Signs / 2020 / March 26
Research for Me @UNC – Do I have to list my study?
Research for Me allows potential participants to reach out directly to you to indicate their interest in your study. We have over 11,000 registered users who are ready to get involved in research at UNC.
Located in Vital Signs / 2020 / March 26
Iweala, Burks Publish Review of Study about IgE-Producing B Cells in Gut Tissues
Onyinye Iweala, MD, PhD, assistant professor in the division of rheumatology, allergy and immunology, and Wesley Burks, MD, Dean of the School of Medicine and CEO of UNC Health, published a review of a recent study looking at how IgE-producing B cells in the gut expand the gut’s role in food allergy.
Located in News / 2020 / May
Cohen Writes Editorial on COVID-19 Prevention Study in NEJM
Myron Cohen, MD, director of the UNC Institute for Global Health and Infectious Diseases, wrote an editorial on the results of a clinical trial to determine efficacy of hydroxychloroquine as prevention of COVID-19.
Located in Vital Signs / 2020 / June 4